Wellstar/TMI Announces Pending Pressure Ulcer Study On Leg And Foot Ulcers

Wellstar International, Inc. (OTCBB: WLSI), a provider of specialized diagnostic software and equipment, announced today that its wholly owned subsidiary, Trillennium Medical Imaging (”TMI”), has begun negotiations for a pressure ulcer study focused on ulcers caused by diabetic foot and venous legs. The Company is currently in talks with several major teaching and research universities, the goal of which is to secure a clinical partner for this study.

More: continued here

Filed under: Clinical Trials on January 16th, 2009